A New Mint1 Isoform, but Not the Conventional Mint1, Interacts with the Small GTPase Rab6 by Thyrock, A. (Anika) et al.
A New Mint1 Isoform, but Not the Conventional Mint1,
Interacts with the Small GTPase Rab6
Anika Thyrock1, Edith Ossendorf1, Martin Stehling2, Mark Kail1, Tanja Kurtz1, Gottfried Pohlentz3,
Dieter Waschbu¨sch1, Simone Eggert5, Etienne Formstecher4, Johannes Mu¨thing3, Klaus Dreisewerd3,
Stefan Kins5, Bruno Goud6, Angelika Barnekow1*
1Department of Experimental Tumorbiology, University Muenster, Muenster, Germany, 2Max Planck Institute for Molecular Biomedicine, Muenster, Germany, 3 Institute
for Hygiene, University Muenster, Muenster, Germany, 4Hybrigenics Services, Paris, France, 5Department of Human Biology and Human Genetics, University
Kaiserslautern, Kaiserslautern, Germany, 6Centre de Recherche, Institute Curie, Paris, France
Abstract
Small GTPases of the Rab family are important regulators of a large variety of different cellular functions such as membrane
organization and vesicle trafficking. They have been shown to play a role in several human diseases. One prominent
member, Rab6, is thought to be involved in the development of Alzheimer’s Disease, the most prevalent mental disorder
worldwide. Previous studies have shown that Rab6 impairs the processing of the amyloid precursor protein (APP), which is
cleaved to b-amyloid in brains of patients suffering from Alzheimer’s Disease. Additionally, all three members of the Mint
adaptor family are implied to participate in the amyloidogenic pathway. Here, we report the identification of a new Mint1
isoform in a yeast two-hybrid screening, Mint1 826, which lacks an eleven amino acid (aa) sequence in the conserved C-
terminal region. Mint1 826, but not the conventional Mint1, interacts with Rab6 via the PTB domain. This interaction is
nucleotide-dependent, Rab6-specific and influences the subcellular localization of Mint1 826. We were able to detect and
sequence a corresponding proteolytic peptide derived from cellular Mint1 826 by mass spectrometry proving the absence
of aa 495–505 and could show that the deletion does not influence the ability of this adaptor protein to interact with APP.
Taking into account that APP interacts and co-localizes with Mint1 826 and is transported in Rab6 positive vesicles, our data
suggest that Mint1 826 bridges APP to the small GTPase at distinct cellular sorting points, establishing Mint1 826 as an
important player in regulation of APP trafficking and processing.
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Introduction
Cellular transport mechanisms are regulated by numerous
proteins involved in signal transduction. Among these are the
members of the Rab protein family, the largest group of small
GTPases within the Ras superfamily [1].They are known to be
involved in a variety of steps during transport processes, such as
membrane docking and fusion, budding events and vesicular
movement along cytoskeletal tracks [2]. One of the most widely
studied Rab GTPases is Rab6, of which four isoforms have been
described: Rab6A, the alternative splice variant Rab6A’, the
tissue-specific form Rab6B and Rab6C, a retrogene derived from
Rab6A’ [3–6]. As a very multifunctional protein, Rab6A is known
to regulate the retrograde vesicular trafficking from the Golgi
apparatus to the endoplasmatic reticulum (ER) via Bicaudal-D [7–
10]. Rab6B is thought to fulfill this task in neuronal cells [11].
Additional functions of Rab6 include the transport of early
endosomes and recycling endosomes towards the trans-Golgi
network and the trafficking of exocytotic vesicles towards the
plasma membrane [10,12,13]. Several studies have also suggested
the involvement of Rab6 in various diseases such as Lowe’s
Syndrome or HIV [14,15]. There is now evidence that the small
GTPase plays a role in the pathology of Alzheimer’s Disease (AD)
[16–20].
AD is the most common neurodegenerative disorder worldwide
[21]. One of the characteristic hallmarks in the pathology of AD is
the presence of extracellular aggregates, consisting of amyloid-beta
(Ab) in the brains of patients [22]. These plaques derive from the
proteolytical cleavage of the amyloid precursor protein (APP), a
type I transmembrane protein [23]. The amyloidogenic processing
is performed sequentially by b- and c-secretases [24–26]. In the
non-amyloidogenic pathway Ab fragments are not produced
because APP is initially cleaved inside the Ab peptide sequence by
a-secretases, followed by c-secretase processing [27–29]. The way
in which APP is cleaved depends on its transport route:
Amyloidogenic processing is thought to take place in endosomes
and lysosomes, whereas the non-amyloidogenic cleavage is
performed mostly at the plasma membrane [30,31].
There are many different proteins that influence the transport
processes of the amyloid precursor protein, among them the Mint
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adaptor proteins, which bind to the C-terminal YENPTY motif of
APP [32]. The family of Mint adaptor proteins comprises three
previously described members: The neuronal Mint1 and Mint2
and the ubiquitously expressed Mint3 [33–35]. The three Mint
proteins have a highly conserved C-terminus, which consists of one
phosphotyrosine-binding (PTB) and two PDZ domains. Mint1
displays an additional Munc-interacting domain and a CASK-
interacting domain [36,37]. Mint proteins seem to be essential for
survival, since Mint1/2 knockout mice die at birth or show a lower
average weight and motor defects [38].
In this manuscript we report the discovery of a new Mint1
isoform, Mint1 826, which lacks an eleven amino acids sequence
in the PTB domain. We show that Mint1 826 is a transcribed gene
by detection of a specific mRNA sequence as well as the
identification of the Mint1 826 protein from tissue samples by
mass spectrometry. In contrast to the previously described Mint1,
we show that it is able to interact with the active form (GTP-
bound) of Rab6 via its PTB domain. Mint1 826 exhibits a different
intracellular distribution in comparison to the previously described
Mint1, as it clearly accumulates in the Golgi area. Our
observations that the deleted sequence does not influence the
ability of Mint1 826 to interact with APP and that Rab6 and APP
co-localize in moving vesicular structures, supports the hypothesis




Human brain and testis samples were obtained from the
Human Gene Bank (which is now part of BrainNet Europe) and S.
Kliesch, Muenster, Germany respectively. For the acquisition of
both samples no approval of an ethics committee was needed since
it took place before 1999. Nevertheless, the patients gave written
informed consent that their tissue could be used for experimental
purposes post mortem as required by law. This consent was
general and not restricted to specific studies, thus there was no
need to contact an ethical review board for this current study.
All animals were housed, cared for, and experiments conducted
in accordance with approved protocols from the University of
Kaiserslautern/"Stadt Kaiserslautern-Referat Umweltschutz",
project number: 15/73/10-Bu approval date: 11.01.2010.
Plasmids. Most of the plasmids used have been described
before [18,39]. To construct the pACT2 Mint1 826 plasmid, the
corresponding sequence was isolated from the yeast two-hybrid
clone pP6 Mint1 (bp1314–2307 D1483–1515) by PvuII cleavage
and inserted into a PvuII cleaved pACT2 Mint1 vector. pGEX
Mint1 826 was created by inserting the SacI fragment from
pACT2 Mint1 826 into a SacI digested pGEX Mint1 vector (the
respective 39 SacI site derived from the Mint1 39 UTR region that
is present in both vectors). APP695-RFP contains a C-terminally
fused mRFP (monomeric red fluorescent protein) tag and was
cloned via PCR based mutagenesis in vector pcDNA3.1, as
described earlier [19]. All of the other plasmids mentioned were
cloned using standard molecular biological techniques.
Antibodies. The monoclonal antibody against GFP (JL8) was
purchased from Clontech, Heidelberg, Germany and diluted
1:4000. For Western blotting, the monoclonal antibody against
Mint1 (A-12) was purchased from Santa Cruz Biotechnology, Inc.,
Heidelberg, Germany and diluted 1:500. For the detection of APP
in Western blot analyses an anti-APP C-term antibody distributed
by Calbiochem, Merck Millipore, Darmstadt, Germany was
applied 1:5000, for detection of APP in immunofluorescence
analyses it was diluted 1:1000. Mint 1 was stained using an
antibody (clone 23) purchased from Becton Dickinson, Heidel-
berg, Germany (1:25). Anti-mouse IgG HRP was purchased from
Cell Signaling Technology H, Danvers, MA, USA and applied
1:1000. For localization studies, intracellular Rab6A was stained
using a monoclonal antibody (5B10, dilution: 1:50) [40], which
was directly conjugated with OY594 by Luminartis GmbH,
Muenster, Germany. The polyclonal antibody against Rab6B
(Institute Curie, Paris, France) was affinity purified and applied at
1:50 dilution. GM130 was stained with an antibody distributed by
Becton Dickinson, Heidelberg, Germany (clone 35, 1:200). As
secondary antibodies, anti-mouse IgG Alexa FluorH488 (Invitro-
gen, Karlsruhe, Germany, 1:1000), anti-mouse IgG Alexa
FluorH647 (Invitrogen, Karlsruhe, Germany, 1:500) and anti-
rabbit IgG Alexa FluorH594 (Invitrogen, Karlsruhe, Germany,
1:1000) were used.
Cell culture. All cell lines used for our studies were cultivated
in DMEM (Biochrom AG, Berlin, Germany) supplemented with
10% fetal calf serum (Pan-Biotech GmbH, Aidenbach, Germany)
and 2 mM glutamine.
CHO K1 (ATCCH number: CCL-61) [18] and HeLa T-RexTM
(Invitrogen, Karlsruhe, Germany) cells have been handled as
described previously [39].
MEF dko APP695 AA12 cells were a kind gift of U. Mu¨ller,
Heidelberg, Germany. In this cell line APP695 and APLP2 were
knocked out and APP695 retransfected [41].
The preparation of primary neurons (isolated from mice
purchased from Janvier, Saint Berthevin Cedex, France) has been
described previously [42].
For localization studies of Mint1 and Mint1 826, 3T3 Swiss cells
(ATCCH number: CCL-92) were transfected with pEGFP Mint1
or pEGFP Mint1 826 respectively using the TurboFectTM
transfection reagent as described in the manufacturer’s manual
(Thermo Fisher Scientific, St. Leon-Rot, Germany). Cells were
fixed 24 h after transfection.
Flow cytometry based FRET analyses. Flow cytometry
based FRET analyses have been performed as described
previously [39].
Yeast two-hybrid analyses. The reporter strain Y190
(Clontech, Heidelberg, Germany) was co-transformed and colo-
nies were analyzed as described previously [8,43].
For the initial Rab6B Q72L screen, the coding sequence of
Rab6B Q72L was cloned into pLex9 as a C-terminal fusion to
LexA. The construct was used as bait to screen at saturation a
highly complex, random-primed human placenta cDNA library
constructed into the plasmid pP6. pLex9 and pP6 derive from the
original pBTM116 [44] and pGADGH [45] plasmids, respective-
ly. More than 130 million clones (13-fold the complexity of the
library) were screened, using a mating with the Y187 (MATa) and
L40DGal4 (MATa) yeast strains as previously described [46].
Positive colonies were selected on a medium lacking tryptophan,
leucine and histidine supplemented with 5 mM 3-aminotriazole.
The prey fragments of the positive clones were amplified by PCR
and sequenced at their 59 and 39 junctions. The resulting
sequences were used to identify the corresponding interacting
proteins in the GenBank database (NCBI) using a fully automated
procedure.
Preparation of mouse brain lysate. Frozen mouse brains
were pestled in liquid nitrogen. The cells were lyzed in
immunoprecipitation (IP) buffer (25 mM Tris pH 8.0, 50 mM
NaCl, 0.5% Triton X-100, Complete EDTA free (Roche
Diagnostics GmbH, Mannheim, Germany)) with a Potter S
homogenizer (10 strokes at 1000 rpm) [47]. Finally, the lysate was
incubated on ice for 30 min and cleared by centrifugation at
150006g for 1 h at 4uC.
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GST pulldown experiments. The expression and prepara-
tion of GST fusion proteins has been carried out as described
before except that an incubation temperature of 37uC was used
instead of 30uC [48]. For the in vitro GST binding assay 10 mg of
the GST Rab6A Q72L fusion protein were bound to 10 ml of
glutathione-SepharoseTM 4B beads (GE Healthcare, Freiburg,
Germany) for 1 h at 4uC in PBS with 1% Triton X-100 and
Complete EDTA free adjusted to 300 ml. Beads were then washed
with PBS/Triton X-100 for three times and incubated overnight
at 4uC with 1 mg of mouse brain lysate, which had been cleared
with GST-coupled glutathione SepharoseTM 4B beads for 3 h at
4uC. After the overnight incubation, beads were washed three
times with IP buffer and bound proteins were eluted from the
beads with sample buffer. Samples were analyzed by SDS-PAGE
(7%) and Western blotting [49].
Other GST pulldown experiments using GST Mint1/Mint1
826 PTB and lysate from stably transfected HeLa T-RExTM cell
lines, GST Rab6 and purified Mint1 826 as well as GST Mint1/
Mint1 826 PTBandMEF lysatewere performed accordingly except
that pulldown buffer (10 mM Tris pH 7.4, 150 mM NaCl, 1 mM
MgCl2, 1 mM CaCl2, 0.2% Triton X-100, Complete EDTA free)
was used instead of IP buffer. Changes in lysate concentrations and
incubation times are stated in the figure legends.
Thrombin cleavage was performed according to the manufac-
turer’s manual (GE Healthcare, Freiburg, Germany).
Immunocytochemistry. To prepare the cells for fluores-
cence analyses, culture dishes were washed three times with PBS
and fixed on ice for 15 min using 4% paraformaldehyde in
250 mM Hepes (pH 7.4). All following steps were performed at
room temperature. Cells were incubated in 8% pre-chilled
paraformaldehyde in 250 mM Hepes (pH 7.4) for 30 min and
washed three times in PBS. After that the coverslips were
quenched for 10 min with 50 mM NH4Cl and after another
washing procedure permeabilized in 0.2% Triton X-100 in PBS
for 5 min. Cells were then washed in a PBS solution containing
0.2% gelatine. Blocking was performed for 30 min in a PBS/0.2%
gelatine solution containing 10% goat serum (University Giessen,
Germany). The primary antibody was diluted in the PBS/0.2%
gelatine solution with 2% goat serum. After a 30 min incubation
in the antibody solution the coverslips were washed three times
with PBS/0.2% gelatine and incubated with the secondary
antibody for 15 min. Finally, the coverslips were washed with
PBS/0.2% gelatine, PBS and distilled water three times each and
mounted with 8 ml of Mowiol 4–88/DABCO (Hoechst, Frankfurt
a.M., Germany).
Quantitative co-localization studies between endogenous
Rab6A and EGFP Mint1 or EGFP Mint1 826 respectively were
performed using the cell‘F software from Olympus, Hamburg,
Germany. First of all, two different regions of interest (ROI) were
defined: One containing the complete cell, the other one
containing the Rab6A staining at the Golgi apparatus. Nonspecific
background staining was substracted by applying the ‘‘Background
Substraction’’ tool using another ROI outside the photographed
cells. Finally, the median gray scales of the complete cell and the
Golgi apparatus were measured by using the option ‘‘Measure’’,
‘‘ROI’’, ‘‘Average Gray Value’’. For comparison of the amount of
Mint1 located in the Golgi area, the ratio of the average gray value
at the Golgi area to the average gray value of the complete cell was
determined.
For co-localization studies betweenMint1 826, APP andGM130,
HeLa cells were plated on glass coverslips (Marienfeld, Lauda
Koenigshofen,Germany) at a density of 35.000 cells/well in a24well
plate one day before transfection. 2–3 hours before transfection, the
media was changed to 500 ml fresh HeLa culture media (DMEM
+10% FBS (HyClone, Thermo Fisher Scientific, St. Leon-Rot,
Germany)+Penicillin/Streptomycin (Sigma-Aldrich Chemie
GmbH, Taufkirchen, Germany) +1% 200 mM L-Glutamin) per
well.1 mgDNA(forco-transfections:260,5 mgDNA)wasmixedwith
87 ml of a 10 mM Tris/HCl pH 7,5 solution and 12,4 ml of a 2 M
CaCl2 solution. Themixture was added to 100 ml 26HBS (280 mM
NaCl, 1,5 mM Na2HPO4, 50 mM HEPES (at a final pH of 7,12–
7,13)) under aeration conditions. Afterwards, the solutionwas added
dropwise toonewell.After3hours incubationat37uCand5%CO2,a
glycerol shock (15%glycerol in16HBS)wasperformed for2minutes
at room temperature. Subsequent two washing steps with plain
DMEM media followed. Then normal HeLa culture media was
added. Cells were fixed 18–20 hours after transfection in 4%
paraformaldehyde/4% sucrose in phosphate buffer solution for 10
minutesat37uC.Thecellswerepermeabilized for10minutesat room
temperature in 0,1%NP40 inPBS andblocked for 1 hour in 5%goat
serum inPBS.TheprimaryantibodyGM130 (cis-Golgimarker,BD-
Bioscience) was added 1:200 overnight in 1% goat serum in PBS at
4uC. The following day, the secondary antibody Alexa-Flour 647
(Molecular Probes, Invitrogen, Karlsruhe, Germany) was added
1:500 in PBS and 1% goat serum for one hour at room temperature
and cells were embedded inMowiol. GFPMint1 826 was visualized
via reflector 488andAPP-RFPvia reflector568.Z-stack imagingwas
performedwith the fluorescencemicroscopeAxio observer Z.1 from
Zeiss with the software Axiovision 4.8.1 and analysis followed via
ImageJ. Co-localization studies between Mint1 826, APP and
GM130 have been performed in primary mouse neurons, addition-
ally.Therefore, thecellshavebeenisolated instageE14.Transfection
of the neurons (seven days in vitro (DIV7)) has been described
previously [50].
Live cell imaging. For live cell imaging, CV1 cells (ATTCH
number: CCL-70) were seeded onto IBIDI 8 well chambers and
transfected with Lipofectamine 2000TM according to the manu-
facturer’s manual. 18 hours after transfection cells were analyzed
with a Zeiss LSM5 live inverted microscope at 37uC. All images
were taken in the LSM mode as 8 bit images using a two-track
recording setup. Green and red channels were recorded sequen-
tially for each time point. Laser power, pinhole and detector gain
were adjusted as needed.
Detection of Mint1/Mint1 826 mRNA. mRNA was isolat-
ed from total RNA (derived from human brain or testis tissue)
using the PolyATtractH mRNA Isolation System II from Promega,
Mannheim, Germany according to the manufacturer’s manual.
This mRNA was used as template for RT PCR (applied kit: First
Strand cDNA Synthesis Kit for RT-PCR, Roche Diagnostics
GmbH, Mannheim, Germany). The resulting cDNA was tested
for the Mint1 826 sequence as described below. The area
containing the deletion was amplified using the primers: 59-
ATCCATGGATTCATTCCCAACCTACGTTG-39and 59-
CTGCTCGAGAGATCTTCGGGGTTAATCC-39. Mint1 826
was detected by applying a specific primer, which recognizes
Mint1 826 but not the conventional Mint1 by binding at the 39
end of exon 5 and the 59 end of exon 7. Primer sequences: 59-
AGCAGGATCAAGGCTCCTG-39 and 59-CTGCTCGAGA-
GATCTTCGGGGTTAATCC-39. Samples were analyzed using
agarose gel electrophoresis (3% NuSieve GTG, Takara, Clontech,
Heidelberg, Germany) and verified by sequencing.
The conventional Mint1 was detected by using the primers 59-
ATCCATGGATTCATTCCCAACCTACGTTG-39and 59-
CTGCTCGAGAGATCTTCGGGGTTAATCC-39. Again, sam-
ples were analyzed using gel electrophoresis and verified by
sequencing.
cDNA libraries were purchased from BD Biosciences, Clontech,
Heidelberg, Germany.
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Sample isolation for mass spectrometry. Mint1/Mint1
826 were immunoprecipitated from 2.5 mg mouse brain lysate
using 2 mg of the A-12 antibody as well as 10 ml Protein G
Sepharose beads (GE Healthcare, Freiburg, Germany) and
separated by SDS-PAGE (7%). Several samples were excised
from the gel and extracted in PBS/0.1% SDS +28 mg/ml
aprotinin (AppliChem, Darmstadt, Germany) at 37uC overnight.
Dissolved protein was desalted using RotiHSpin centrifugation
tubes (30 kDa cut off, Carl-Roth GmbH, Karlsruhe, Germany)
and concentrated by vacuum centrifugation. Subsequently,
samples were separated by SDS-PAGE.
In-gel digest. Coomassie-stained protein bands were excised
and cut into smaller pieces. Subsequently, 500 ml of pure
acetonitrile (ACN, Merck, Darmstadt, Germany) was added and
the mixture was shaken until the gel became white and shrank.
The supernatant was removed and the gel pieces were dried in
vacuo. The dried gel pieces were allowed to soak thermolysin
(Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) solution
(0.25 mg/ml) at ambient temperature for 30 min. The excess of
protease solution was removed and the gel pieces were covered
with 25 mM ammonium hydrogen carbonate and incubated over
night at 65uC. Proteolytic peptides were subsequently extracted
with 250 ml of 25 mM ammonium hydrogen carbonate (Fluka,
Buchs, Switzerland), 50% ACN/2.5% formic acid (FA, Merck,
Darmstadt, Germany), 80% ACN/2.5% FA, and pure ACN. The
combined extracts were dried in vacuo.
ZipTip C18-desalting. For desalting of in-gel digested
proteins ZipTip pipette tips (Millipore, Billerica, USA) were
equilibrated three times with 10 ml of 50% ACN and five times
with 10 ml of 0.1% Trifluoroacetic acid (TFA, Carl-Roth GmbH,
Karlsruhe, Germany). The proteolytic peptides were dissolved in
10 ml of 0.5% TFA and loaded onto the tips. After washing three
times with 10 ml of 0.1% TFA the peptides were eluted five times
with 10 ml of 50% ACN/0.1% TFA, five times with 10 ml of 50%
ACN/0.1% TFA, and three times with 10 ml of pure ACN. The
combined eluates were dried in vacuo and redissolved in 10 ml of
40% methanol/0.5% FA (Merck, Darmstadt, Germany) for mass
spectrometric analysis.
Mass spectrometry (MS). The proteolytic peptides derived
from in-solution digests were analyzed by nano electrospray
ionization (nanoESI). Performing MS/MS experiments on peptide
ions allowed for deducing their amino acid sequences from
fragment ion spectra. NanoESI MS experiments were carried out
by use of a SYNAPT G2-S mass spectrometer (Waters,
Manchester, UK) equipped with a Z-spray source in the positive
ion sensitivity mode. Typical source parameters were: source
temperature: 80uC, capillary voltage: 0.8 kV, sampling cone
voltage: 20 V, and source offset voltage: 50 V. For low energy
collision induced dissociation (CID) experiments, the peptide
precursor ions were selected in the quadrupole analyser, subjected
to ion mobility separation (IMS; wave velocity 850 m/s, wave
height 40 V, nitrogen gas flow rate 90 ml/min, and helium gas
flow rate 180 ml/min), and fragmented in the transfer cell using a
collision gas (Ar) flow rate of 2.0 ml/min and collision energies up
to 100 eV (Elab).
Results
A Novel Mint1 Isoform, Mint1 826, Interacts with Rab6
To search for new interacting partners of Rab6B, a yeast two-
hybrid (YTH) screen was performed using Rab6B Q72L as the
bait protein and a human placenta cDNA library as prey. A clone
was isolated that contained a fragment, which was identified as
Mint1 (pP6 Mint1, aa 438–769) by partially sequencing from both
ends. Besides the tissue-specific Rab6B, also the ubiquitously
expressed Rab6A and Rab6A’ displayed a significant interaction
signal with pP6 Mint1 (Table 1). On the other hand, pP6 Mint1
did not interact with a variety of other Rab GTPases including
RhoA, H-Ras and Ypt6, the yeast homologue of Rab6 (Table 1).
Next, we investigated the cellular expression pattern of Mint1
and compared it with Rab6. Since Mint1 has been described as
neuron specific, we chose primary mouse neurons as model and
co-stained endogenous Mint1 with the neuronal Rab6 isoform
Rab6B (Figure 1). A clear partial co-localization of Mint1 (which
we later found out was not the previously described form of Mint1)
and Rab6B was observed in the Golgi area.
Subsequently, we tested, whether the full length Mint1 protein
was able to interact with Rab6 in the YTH system. The cDNA for
the respective expression construct, encoding the entire Mint1
sequence (NM_001163.3), was obtained from J.P. Borg (Marseille
University, France). To our surprise, the full length Mint1 did not
interact with either Rab6A or Rab6B (Table 2). Since the Rab6
positive Mint1 clone that was isolated from the YTH screen was
only partially sequenced, we sequenced the whole construct to
explain the discrepancy. Interestingly, the YTH clone differed
from the so far known Mint1 sequence by the absence of exon 6
(bp, 1483–1515, representing aa 495–505), suggesting that the
deletion of this exon enables the interaction of Mint1 with Rab6.
In further experiments, we constructed a full length Mint1 with the
corresponding deletion and called the new Mint1 variant Mint1
826 (in comparison to the 837-aa-long conventional Mint1). In
yeast co-transformation experiments, Mint1 826 showed a strong
interaction with the constitutively active form of Rab6A (Table 3).
In addition, we were able to show that the neuron specific Rab6
Table 1. Rab specificity of the interaction with Mint1.
prey plasmid bait plasmid his3 b -gal
pP6 Mint1 (aa 438–769) pAS Rab6A Q72L +++ +++
pAS Rab6A‘ Q72L +++ +++
pAS Rab6B Q72L +++ +++
pAS Rab1A wt 2 2
pAS Rab1B wt 2 2
pAS Rab1B Q67L 2 2
pAS Rab2 wt 2 2
pAS Rab2 Q65L 2 2
pAS Rab3A wtDC 2 2
pAS Rab11A wt 2 2
pAS Rab33B wt 2 2
pAS Rab33B Q92L 2 2
pAS Rab33B T47N 2 2
pAS RhoA wt 2 2
pAS H-Ras wt DC 2 2
pAS Ypt6p wt 2 2
pAS Ypt6p Q69L 2 2
pAS Ypt1 wt 2 2
After co-transformation, Y190 strains were cultivated in synthetic media lacking
leucine, tryptophan and histidine, supplemented with 30 mM 3 AT (his3). b-
galactosidase reporter gene activity was determined on replica filters using X-
gal as substrate (b -gal).
– no growth on selection media or staining in b-galactosidase filter
assay,+++very strong growth on selection media or staining in b-galactosidase
filter assay, DC: without prenylation site.
doi:10.1371/journal.pone.0064149.t001
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isoform Rab6B is also able to interact with Mint1 826, which is
especially remarkable, considering that Mint1 is also neuron
specific. A positive b-galactosidase signal was not detected with
Mint1 826 and the inactive Rab6 mutants (Table 3), proving that
the interaction of Mint1 826 is nucleotide-dependent. These
results support the hypothesis that the deletion of the 11 amino
acid sequence in Mint1 826 is responsible for the adaptor protein’s
ability to bind Rab6.
In the next step, we mapped the binding region of Mint1
interacting with the small GTPase by using truncated mutants.
Previous studies have shown that the PTB domain of Mint3 is able
to interact with Rab6A [18] and Rab6B (data not shown). To test,
whether this applies to the new Mint1 variant, we generated a
clone that contained the PTB domain only (Mint1 826 PTB, aa
438–625 D 495–505). In YTH experiments, Mint1 826 PTB was
able to interact with Rab6A/B Q72L and Rab6A/B wildtype, but
not with the inactive mutants, indicating that the PTB domain is
the region of interaction for both Rab6 isoforms (Table 4). As
expected, the PTB domain of the conventional Mint1 (Mint1 PTB)
showed no interaction with Rab6 (Table 4). We could confirm the
above results by GST pulldown experiments (Figure 2A and 2B).
Thus the deletion of the 11 aa sequence in Mint1 826 enables the
protein to interact with Rab6 and that the area of the interaction is
the PTB domain.
Although YTH in vivo experiments and in vitro studies like GST
pulldown analyses are potential tools for detecting protein-protein
interactions, a confirmation of the interplay in living mammalian
cells is advantageous. One attractive method to prove that proteins
interact in living cells is to use flow cytometry based FRET
analysis. As additional protein components or adaptor proteins
would lead to a higher distance between the CFP and the YFP
fluorophor and therefore inhibit the energy transfer, a FRET
signal also indicates a direct interaction between the tested
proteins. As shown in Figure 3, a FRET signal could be detected in
cells that were co-transfected with pECFP Rab6A/B Q72L and
pEYFP Mint1 826 PTB, but not in cells expressing ECFP Rab6A/
B Q72L and EYFP Mint1 PTB (Figure 3). This demonstrates that
Rab6 and Mint1 826 specifically interact in vivo.
The results presented so far indicate that the newly discovered
Mint1 variant, lacking exon 6, is able to interact with Rab6A and
Rab6B via its PTB domain, whereas the previously described
Mint1 protein appears not to be an interacting partner.
Biochemical experiments as well as studies in living human cells
showed that the interaction is direct, nucleotide-dependent and
Rab6-specific.
Mint1 826 is Expressed Endogenously on mRNA and
Protein Level
Due to the lack of an antibody able to discriminate between
Mint1 826 and Mint1, finding evidence for Mint1 826 via
standard Western blot analyses was not possible. We therefore set
out to show that Mint1 826 is a transcribed gene by detection of
the specific mRNA sequence. During a search of the EST
database we identified an EST clone (BE937843.1) that corre-
Figure 1. Co-localization studies with Rab6 and Mint1. Co-staining of Mint1 and Rab6B in primary mouse neurons. Cells were treated with
anti-Mint1 and anti-mouse Alexa488 as well as anti-Rab6B and anti-rabbit Alexa594 antibodies. Scale bar: 20 mm.
doi:10.1371/journal.pone.0064149.g001
Table 2. Full length Mint1 does not interact with Rab6.
prey plasmid bait plasmid his3 b-gal
pACT Mint1 pAS Rab6A Q72L 2 2
pAS Rab6A T27N 2 2
pAS Rab6B Q72L 2 2
pAS Rab6B T27N 2 2
pAS 2–1 2 2
After co-transformation, Y190 strains were cultivated in synthetic media lacking
leucine, tryptophan and histidine, supplemented with 30 mM 3 AT (his3). b-
galactosidase reporter gene activity was determined on replica filters using X-
gal as substrate (b-gal). Mint1 (NM_001163.3) was tested against the
constitutively active or inactive variant of either Rab6A or Rab6B.
– no growth on selection media or staining in b-galactosidase filter assay.
doi:10.1371/journal.pone.0064149.t002
Table 3. Mint1 826 interacts with GTP-bound Rab6.
prey plasmid bait plasmid his3 b-gal
pACT Mint1 826 pAS Rab6A Q72L ++ +++
pAS Rab6A T27N 2 2
pAS Rab6B Q72L +++ +++
pAS Rab6B T27N 2 2
pAS 2–1 2 2
After co-transformation, Y190 strains were cultivated in synthetic media lacking
leucine, tryptophan and histidine, supplemented with 30 mM 3 AT (his3). b-
galactosidase reporter gene activity was determined on replica filters using X-
gal as substrate (b-gal). Mint1 826, which lacks aa 495–505 in comparison to the
conventional Mint1, was tested against the constitutively active or inactive
variant of either Rab6A or Rab6B.
– no growth on selection media or staining in b-galactosidase filter
assay,++strong growth on selection media or staining in in b-galactosidase filter
assay,+++very strong growth on selection media or staining in b-galactosidase
filter assay.
doi:10.1371/journal.pone.0064149.t003
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sponded to the Mint1 826 sequence. We then searched for
evidence of Mint1 826 expression in different types of tissue and
cell lines. We designed a Mint1 826 specific primer (see Materials
and Methods), which did not recognize the conventional Mint1
and used it to amplify a 401 bp fragment of Mint1 826 (Figure 4A).
We first analyzed cDNA libraries representing different tissue
types (Figure 4). Interestingly, Mint1 826 displayed a tissue-specific
transcription pattern. Apart from some minor signals resulting
from non-specific primer binding, a clear Mint1 826 signal was
detected in probes of human testis and brain but not in lung, liver
or spleen. To extend these results, we isolated total RNA from
human brain and testis tissue as well as from murine brain,
extracted mRNA from the samples and performed RT-PCRs. The
cDNA was tested using the Mint1 826 specific primer. A distinct
signal was detected in murine and human brain as well as in
human testis samples. Together these data indicate that the
endogenous human and murine Mint1 826 is predominantly
transcribed in brain and testis (Figure 4). Additionally, we tested
the mentioned libraries and tissue samples for the existence of the
conventional Mint1. Surprisingly, it was found in all samples that
also contained Mint1 826, although it has been described as being
transcribed and expressed neuron-specific [33] (Figure 4B). The
fact that the conventional Mint1 was found in all samples that also
contained Mint1 826, strengthens the fact that Mint1 826 is not a
product of accidental exon-skipping processes, neither in tissues
nor in cell cultures.
While the presence of an mRNA transcript is strong evidence
for the existence of a specific protein, it is not an ultimate proof.
We thus performed GST pulldown experiments with GST Rab6A
Q72L to isolate endogenous Mint1 826 from mouse brain. An
immunoreactive band was detected in the GST Rab6A Q72L
sample, but not in lysates incubated with GST Rab6A T27N or
GST alone (Figure 5). The blotting membrane was incubated with
a Mint1 specific antibody, which recognizes the N-terminus of the
protein and is therefore able to recognize both Mint1 variants.
Since we showed that only Mint1 826 but not Mint1 can bind to
Rab6 using a variety of methods, this pulldown experiment
strongly indicates that not only the transcript, but also the Mint1
826 protein is present in mouse brain tissue and that this
endogenous Mint1 826 can interact with Rab6.
To confirm these findings we additionally analyzed Mint1 826
from mouse brain by mass spectrometry (Figure 6). Immunopre-
cipitated Mint1 protein (representing Mint1 as well as Mint1 826)
was separated by SDS PAGE and the corresponding band was
excised and subjected to in-gel digest by thermolysin as described
in the Materials and Methods section. The resulting peptides were
analyzed by nanoESI MS. Direct fragmentation of the doubly
charged candidate precursor ions at m/z 945.96 in the trap cell of
the hybrid mass spectrometer did not lead to clear-cut fragment
Figure 2. Verification of the interaction between Mint1 826 and Rab6 isoforms using GST pulldown experiments. 10 ml of Glutathione
SepharoseTM 4B beads were coated with GST or the denoted GST fusion protein and then incubated with the designated prey protein. Samples were
analyzed by Western blotting using an anti-GFP (a) or anti-Mint1 (b) antibody. QL: constitutively active variant (Q72L), TN: inactive variant (T27N). A)
5 mg of the GST Mint 1 fusion proteins were incubated with lysates of stably transfected HeLa T-RExTM cells overexpressing Rab6 GFP or CFP fusion
proteins (206input) for 1.5 h at 4uC. B) 1 mg of the GST Rab6 fusion protein was incubated with 300 ng of Mint 826 for 1 h at 4uC. Mint1 826 was
isolated from thrombin cleaved bacterially expressed GST Mint1 826. input: 50 ng Mint1 826.
doi:10.1371/journal.pone.0064149.g002
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ion spectra, possibly because of co-extracted compounds of similar
m/z values. Therefore, the selected precursor ions were first
separated by means of ion mobility and subsequently fragmented
in the transfer cell of the instrument. Due to the extremely low
abundance of Mint1 826, the CID spectrum still contained a
relatively high fragment ion background. However, the clearly
detectable almost complete series of b type ions, amended by a
number of complementary y type ions (depicted in Figure 6A and
B) unambiguously prove the presence of the peptide IK
APEGESQPMT EVDLF, which lacks the 11 aa sequence found
in the conventional Mint1 (Figure 6C).
Functional Analyses of the Interaction between Mint1
826 and Rab6
We next tested, whether Mint1 826 can interact with APP and
whether it co-localizes with Rab6 and APP on the subcellular level.
The interaction of Mint1 with APP via the PTB domain is well
documented [32]. To show that Mint1 826 is also capable to bind
APP despite the lack of the 11 aa sequence, we performed
appropriate GST pulldown experiments. GST fusion proteins of
truncated mutants of Mint1 826 (Mint1 826 PTB) as well as Mint1
(Mint1 PTB) were able to bind APP695 from MEF dKO APP695
cell lines (Figure 7). These results were confirmed using GST
Mint1 826 PTB/GST Mint1 PTB and lysate from CHO cells,
which were transfected with pEGFP APP695 and lysed 48 h after
transfection (data not shown). Additionally, we examined, whether
GST Rab6 could bind APP directly, but it turned out that neither
GST Rab6A nor GST Rab6B was able to associate with the
amyloid precursor protein (data not shown).
Further we performed immunocytochemical studies on neuro-
nal cells and non-neuronal cell lines to test for co-localization of
Mint1 826 with Rab6 and APP. Analyses of transiently transfected
3T3 Swiss cells with either pEGFP Mint1 or pEGFP Mint1 826
respectively revealed that Mint1 826 is predominantly localized to
the Golgi area, whereas Mint1 is distributed evenly in the
cytoplasm with no specific accumulation in any cellular compart-
ment (Figure 8A). The quantitative determination of the Mint1 or
Mint1 826 level in the Golgi area in comparison to the total
amount of the protein inside the cell emphasizes these results
(Figure 8B). A similar subcellular distribution of endogenous
Mint1/Mint1 826 was observed in primary neurons (Figure 9A).
Interestingly, co-staining of EGFP Mint1 826 and Rab6A revealed
that both proteins accumulate and co-localize to a high degree in
the Golgi area (Figure 8A). Consistently, immunocytochemical
analysis of primary mouse neurons transfected with pCDNA3.1
APP696 RFP and pEGFP Mint1 826 revealed that Mint1 826 and
APP co-localize with GM130 in HeLa cells as well as in primary
mouse neurons at those sites where GFP Mint1 826 accumulates,
Table 4. Mapping of the Mint1 826 interacting domain.
prey plasmid bait plasmid his3 b-gal
pACT Mint1 826 PTB (aa 438–625
D495–505)
pAS Rab6A wt ++ ++
pAS Rab6A Q72L ++ +++
pAS Rab6A T27N 2 2
pAS Rab6B wt ++ ++
pAS Rab6B Q72L ++ +++
pAS Rab6B T27N 2 2
pAS 2–1 2 2
pACT Mint1 PTB (aa 438–625) pAS Rab6A wt 2 2
pAS Rab6A Q72L 2 2
pAS Rab6A T27N 2 2
pAS Rab6B wt 2 2
pAS Rab6B Q72L 2 2
pAS Rab6B T27N 2 2
pAS 2–1 2 2
After co-transformation, Y190 strains were cultivated in synthetic media lacking
leucine, tryptophan and histidine, supplemented with 30 mM 3 AT (his3). b-
galactosidase reporter gene activity was determined on replica filters using X-
gal as substrate (b-gal). Mint1 (NM_001163.3) PTB was tested against the
wildtype or the constitutively active or inactive variant of either Rab6A or
Rab6B. Mint1 826 PTB, which lacks aa 495–505 in comparison to the
conventional Mint1 was as well tested against the wildtype or the constitutively
active or inactive variant of either Rab6A or Rab6B.
– no growth on selection media or staining in b-galactosidase filter
assay,++strong growth on selection media or staining in in b-galactosidase filter
assay,+++very strong growth on selection media or staining in b-galactosidase
filter assay.
doi:10.1371/journal.pone.0064149.t004
Figure 3. Flow cytometry based FRET analyses. HeLa T-REx cells were co-transfected with the indicated plasmids. Cells transfected with ECFP
Rab6 and EYFP-C1 empty vector served as negative, EYFP–ECFP fusion protein as positive control. The graph displays EYFP fluorescence (550 nm)
from 405 nm excitation of ECFP- and EYFP-double positive cells after correction of spectral bleeding of ECFP into the FRET (550 nm) channel and
direct excitation of EYFP by the 405 nm laser line.
doi:10.1371/journal.pone.0064149.g003
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namely in the Golgi area and in vesicular structures at the
periphery of the cells (Figure 9A and B). GM130 like Rab6 is
known to localize specifically to the Golgi area [51].This supports
our assumption that Mint1 826 is involved in APP sorting in the
Golgi and possibly also in the trans-Golgi network and in the
secretory pathway. The latter postulation is further supported by
live cell imaging studies, showing that Rab6B Q72L and APP
clearly co-localize in moving vesicles in the cell periphery (Figure 9
C, Movie S1). Unfortunately, live cell imaging of Mint1 826 could
not be carried out due to the toxicity of the overexpressed protein
(data not shown).
In conclusion, the demonstration that endogenous Mint1 826
interacts with both APP and Rab6 proteins, as well as the co-
localization of APP and Rab6B in moving vesicular structures,
support a functional interaction between these proteins. Hereby
Mint1 826 might serve as an adaptor protein for the Rab6
regulated transport of APP inside the cell.
Discussion
In this study, we identified a novel Mint1 variant lacking exon 6,
called Mint1 826. We showed that this is a transcribed gene by
detection of a specific mRNA sequence and demonstrated the
presence of the endogenous protein in tissue samples. This protein
is, in contrast to the previously described Mint1 [33], capable of
interacting specifically in a nucleotide-dependent manner with the
small GTPase Rab6 via its PTB domain. Previous studies in our
group demonstrated that the ubiquitously expressed Mint3 is
similarly able to bind to GTP-bound Rab6A [18]. Interestingly, in
Mint3 the same amino acids are missing in its PTB domain as in
Mint1 826, implying that Mint proteins are able to bind to Rab6,
when displaying this eleven amino acids deletion.
Our results show that Mint1 and Mint1 826 do not display the
same subcellular localization. Mint1 is distributed evenly in the
cell, whilst Mint1 826 is highly concentrated in the Golgi area,
where it clearly co-localizes with Rab6 (Figure 8). Additional
analyses of HeLa cells and primary mouse neurons revealed that
Mint1 826 clearly co-localizes with APP 695 and the Golgi marker
GM130 (Figure 9A and B). These results suggest an interplay of
Mint1 826 and Rab6 in APP sorting. Rab6 also appears to be
involved in vesicular APP transport (Figure 9 C), in agreement
with previous studies. In 1996 McConlogue and colleagues
showed that overexpression of APP and an inactive Rab6A
mutant leads to an increased production of soluble APPa by
promoting the transport of APP to the plasma membrane [16].
Furthermore, it has been shown that Rab6 promotes the
retrograde trafficking of APP from the Golgi apparatus to the
ER [17]. On the other hand, more recent studies showing that
Rab6 is involved in the transport of exocytotic vesicles towards the
Figure 4. Detection of Mint1 826 mRNA. Various types of cDNA libraries derived from lung, liver, spleen, testis and brain were analyzed for the
existence of Mint1 826. For this purpose a Mint1 826 specific primer that does not amplify the conventional Mint1 (tested using a linearized pACT
Mint1 vector as a template, negative control) was applied in PCR analyses containing the libraries as templates. Positive results were confirmed
utilizing mRNA isolated from the respective tissues. Additionally, the respective samples were also tested for the existence of the conventional Mint1
mRNA. A) Mint1 826-specific PCR analyses using RNA from human brain and human testis tissues. B) Summary of the Mint1/Mint1 826-specific PCR
analyses.
doi:10.1371/journal.pone.0064149.g004
Figure 5. Detection of the Mint1 826 protein. For detection of the
Mint1 826 protein GST pulldown assays were performed. 10 ml of
Glutathione SepharoseTM 4B beads were coated with 10 mg of GST or
the denoted GST fusion protein and then incubated with 1 mg of
mouse brain lysate for 3 h at 4uC. Since Mint1 826 seems to exhibit a
relatively low expression level, three samples were pooled for Western
blot analyses. input: 15 mg mouse brain lysate.
doi:10.1371/journal.pone.0064149.g005
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Figure 6. Detection of Mint 826 by mass spectrometry. A) NanoESI fragment ion spectrum obtained from a CID experiment on the ion
mobility-separated doubly charged peptide precursor ions at m/z 945.96 derived from an in-gel proteolytic digest by thermolysin of immuno-
precipitated Mint1 826 protein. B) Corresponding fragmentation scheme. C) Schematic illustration of both Mint1 isoforms. Highlighted in red: 11 aa
sequence deleted in Mint1 826.
doi:10.1371/journal.pone.0064149.g006
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plasma membrane via kinesin-1 and the fusion of the vesicles with
their target membrane shed new light on the putative role of Rab6
in APP transport [13,52]. APP is likely to be one cargo of Rab6
that is transported to the plasma membrane, where it is processed
in the non-amyloidogenic pathway [25]. Our live cell imaging data
support this hypothesis. Rab6B and APP positive vesicles were
indeed primarily found in the cell periphery moving towards the
plasma membrane (Figure 9 C, Movie S1).
Mint1 826 might be an important adaptor that links Rab6 to its
APP cargo. Our studies in primary neurons (Figure 1) support this
hypothesis. GST pulldown analyses have shown that Rab6 is not
able to bind APP directly (data not shown), suggesting that Mint1
826, which is not only able to bind Rab6, but also APP, could
indeed be an adaptor protein for this transport process and
therefore might be an important player in the development of
Alzheimer’s Disease.
A variety of studies have pointed to the potential neuroprotec-
tive effect of Rab6 and Mint proteins by regulating the cellular
level of Ab [53]. The overexpression of Mint3 results in a decrease
in the production of Ab. When the adaptor protein is knocked
down, APP transport to the endosomes is increased, which favors
processing of APP via the amyloidogenic pathway [53]. It has also
been shown that Mint2 controls mechanisms that lead to an
accumulation of immature APP in the early secretory pathway
therefore suppressing the generation of amyloid beta [54].
Furthermore, studies in mice support the hypothesis that Mint
proteins play an important role in the development of AD: AD
transgenic mouse models with a Mint1 insufficiency showed an
increase in Ab production [55].
How the different transport processes involving Mint1 826
compare to those regulated by conventional Mint1 has yet to be
established. Several groups have already studied the regulation of
the Mint adaptor proteins and the impact on APP processing. It
has been shown that Mint1 activity is controlled by autoinhibitory
mechanisms [56]. In the autoinhibited state the C-terminus of
Mint1 binds to the PTB domain and so undergoes a conforma-
tional change, which leads to the loss of its APP binding affinity. It
is assumed that a phosphorylation of the Tyr633 residue by
members of the Src family of non receptor tyrosine-kinases might
be the reason for the structural alteration [56]. Indeed, previous
studies have shown that Mint proteins are phosphorylated by Src
kinases, which influences the intracellular distribution of APP [31].
Future studies will have to clarify, whether these mechanisms
apply to the Mint1 826 isoform.
Further investigation on the relation between Rab6, Mint1 826
and APP appears challenging. Although Mint1 knock-out mice are
available [38], they most likely show a lack of both the
conventional Mint1 and Mint1 826. Also Rab6 knock-out/
knock-down experiments do not seem to be appropriate for
additional studies, since the different isoforms perform highly
overlapping tasks and therefore might be redundant. Nevertheless,
additional experiments, comparing the expression levels of Mint1
826 in tissue samples from AD patients, would be informative. Our
immunofluorescence analyses showed a partial co-localization
Figure 7. Verification of the interaction between Mint1 826 and
APP. 10 ml of Glutathione SepharoseTM 4B beads were coated with
5 mg of GST or the denoted GST Mint1 fusion proteins and then
incubated with MEF dko APP695 AA12 cell lysates (20 x input) for 1.5 h
at 4uC. Samples were analyzed by Western blotting using an anti-APP C-
terminus antibody.
doi:10.1371/journal.pone.0064149.g007
Figure 8. Intracellular distribution of Mint1 826 and Mint1. 3T3 Swiss cells were transiently transfected with either pEGFP Mint1 826 or pEGFP
Mint1. 24 h after transfection cells were fixed and co-stained with a Rab6A specific antibody (5B10), which was conjugated with OY594 directly. A)
Co-localization studies of endogenous Rab6A with EGFP Mint1 826 or EGFP Mint1, respectively. B) Quantitative analyses of the cellular distribution of
Mint1/Mint1 826. Cells from two independent experiments were evaluated with the Cell‘F software (Olympus) by calculating the ratio between the
average gray value of Mint1 at the Golgi apparatus and the average gray value of Mint1 in the total cell. Statistical significance was tested via
student’s t-test, n = 80.
doi:10.1371/journal.pone.0064149.g008
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between Rab6 and Mint1 (Figure 1). Interestingly, such a co-
localization was detected in a restricted number of cells only. The
stained protein represents both forms of the adaptor, Mint1 as well
as Mint1 826. The fact that rather small areas in a few numbers of
cells offer co-localizations with Rab6 indicates that only a low
percentage of the cellular Mint1 represents Mint1 826. Whether
this ratio is imbalanced in brains of patients suffering from AD has
yet to be examined.
The discovery of the new Mint1 826 isoform along with recent
results from other research groups including our own group
provide new insights into the transport mechanisms involving
Rab6, the Mint adaptor proteins and the processing of APP. Yet,
further research needs to be performed to establish a more detailed
understanding of the complex cellular machineries that are
involved in the pathology of AD.
Supporting Information
Movie S1 Live cell imaging of Rab6B and APP. CV1 cells were
co-transfected with pDsRed monomer Rab6B Q72L and pEGFP
APP 695 and imaged 18 h after transfection.
(AVI)
Figure 9. Fluorescence analyses of Rab6, Mint1 826 and APP. A) Co-staining of Mint1 826, APP and GM130 in HeLa cells. Cells were co-
transfected with pEGFP Mint1 826 and pCDNA3.1 APP 695 RFP and subsequently incubated with anti-GM130 and anti-mouse Alexa488 antibodies.
Scale bar: 20 mm. B) Co-staining of Mint1 826, APP and GM130 in primary mouse neurons. Cells were co-transfected with pEGFP Mint1 826 and
pCDNA3.1 APP 695 RFP and subsequently incubated with anti-GM130 and anti-mouse Alexa488 antibodies. Scale bar: 20 mm. C) Live cell imaging of
Rab6B and APP. CV1 cells were co-transfected with pDsRed monomer Rab6B Q72L and pEGFP APP 695 and imaged 18 h after transfection.
doi:10.1371/journal.pone.0064149.g009
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